Global OTC Anti-Infective Medications Market Insights, Forecast to 2029
This report presents an overview of global market for OTC Anti-Infective Medications market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of OTC Anti-Infective Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for OTC Anti-Infective Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the OTC Anti-Infective Medications revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global OTC Anti-Infective Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for OTC Anti-Infective Medications revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche and NanoViricides, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of OTC Anti-Infective Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Anti-Infective Medications revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of OTC Anti-Infective Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for OTC Anti-Infective Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the OTC Anti-Infective Medications revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global OTC Anti-Infective Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for OTC Anti-Infective Medications revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche and NanoViricides, etc.
By Company
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis
- Abbott
- Sanofi
- Bristol-Myers Squibb
- Roche
- NanoViricides
- Novabay Pharmaceuticals
- Optimer Pharmaceuticals
- Basilea Pharmaceutica
- MerLion Pharma
- Antifungals
- Antiseptic
- Antiparasitics
- Hospital Pharmacies
- Drug Stores
- E-Commerce
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of OTC Anti-Infective Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Anti-Infective Medications revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Anti-Infective Medications Market Perspective (2018-2029)
2.2 Global OTC Anti-Infective Medications Growth Trends by Region
2.2.1 OTC Anti-Infective Medications Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2018-2023)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2024-2029)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue OTC Anti-Infective Medications by Players
3.1.1 Global OTC Anti-Infective Medications Revenue by Players (2018-2023)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2018-2023)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Anti-Infective Medications, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2022
3.5 Global Key Players of OTC Anti-Infective Medications Head office and Area Served
3.6 Global Key Players of OTC Anti-Infective Medications, Product and Application
3.7 Global Key Players of OTC Anti-Infective Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC ANTI-INFECTIVE MEDICATIONS BREAKDOWN DATA BY TYPE
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2018-2023)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2024-2029)
5 OTC ANTI-INFECTIVE MEDICATIONS BREAKDOWN DATA BY APPLICATION
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2018-2023)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America OTC Anti-Infective Medications Market Size (2018-2029)
6.2 North America OTC Anti-Infective Medications Market Size by Type
6.2.1 North America OTC Anti-Infective Medications Market Size by Type (2018-2023)
6.2.2 North America OTC Anti-Infective Medications Market Size by Type (2024-2029)
6.2.3 North America OTC Anti-Infective Medications Market Share by Type (2018-2029)
6.3 North America OTC Anti-Infective Medications Market Size by Application
6.3.1 North America OTC Anti-Infective Medications Market Size by Application (2018-2023)
6.3.2 North America OTC Anti-Infective Medications Market Size by Application (2024-2029)
6.3.3 North America OTC Anti-Infective Medications Market Share by Application (2018-2029)
6.4 North America OTC Anti-Infective Medications Market Size by Country
6.4.1 North America OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America OTC Anti-Infective Medications Market Size by Country (2018-2023)
6.4.3 North America OTC Anti-Infective Medications Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe OTC Anti-Infective Medications Market Size (2018-2029)
7.2 Europe OTC Anti-Infective Medications Market Size by Type
7.2.1 Europe OTC Anti-Infective Medications Market Size by Type (2018-2023)
7.2.2 Europe OTC Anti-Infective Medications Market Size by Type (2024-2029)
7.2.3 Europe OTC Anti-Infective Medications Market Share by Type (2018-2029)
7.3 Europe OTC Anti-Infective Medications Market Size by Application
7.3.1 Europe OTC Anti-Infective Medications Market Size by Application (2018-2023)
7.3.2 Europe OTC Anti-Infective Medications Market Size by Application (2024-2029)
7.3.3 Europe OTC Anti-Infective Medications Market Share by Application (2018-2029)
7.4 Europe OTC Anti-Infective Medications Market Size by Country
7.4.1 Europe OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe OTC Anti-Infective Medications Market Size by Country (2018-2023)
7.4.3 Europe OTC Anti-Infective Medications Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China OTC Anti-Infective Medications Market Size (2018-2029)
8.2 China OTC Anti-Infective Medications Market Size by Type
8.2.1 China OTC Anti-Infective Medications Market Size by Type (2018-2023)
8.2.2 China OTC Anti-Infective Medications Market Size by Type (2024-2029)
8.2.3 China OTC Anti-Infective Medications Market Share by Type (2018-2029)
8.3 China OTC Anti-Infective Medications Market Size by Application
8.3.1 China OTC Anti-Infective Medications Market Size by Application (2018-2023)
8.3.2 China OTC Anti-Infective Medications Market Size by Application (2024-2029)
8.3.3 China OTC Anti-Infective Medications Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia OTC Anti-Infective Medications Market Size (2018-2029)
9.2 Asia OTC Anti-Infective Medications Market Size by Type
9.2.1 Asia OTC Anti-Infective Medications Market Size by Type (2018-2023)
9.2.2 Asia OTC Anti-Infective Medications Market Size by Type (2024-2029)
9.2.3 Asia OTC Anti-Infective Medications Market Share by Type (2018-2029)
9.3 Asia OTC Anti-Infective Medications Market Size by Application
9.3.1 Asia OTC Anti-Infective Medications Market Size by Application (2018-2023)
9.3.2 Asia OTC Anti-Infective Medications Market Size by Application (2024-2029)
9.3.3 Asia OTC Anti-Infective Medications Market Share by Application (2018-2029)
9.4 Asia OTC Anti-Infective Medications Market Size by Region
9.4.1 Asia OTC Anti-Infective Medications Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia OTC Anti-Infective Medications Market Size by Region (2018-2023)
9.4.3 Asia OTC Anti-Infective Medications Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.5.5 Abbott Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.8.5 Roche Recent Developments
11.9 NanoViricides
11.9.1 NanoViricides Company Details
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.9.5 NanoViricides Recent Developments
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Details
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.10.5 Novabay Pharmaceuticals Recent Developments
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Details
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.11.5 Optimer Pharmaceuticals Recent Developments
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Details
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.12.5 Basilea Pharmaceutica Recent Developments
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Details
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.13.5 MerLion Pharma Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global OTC Anti-Infective Medications Market Perspective (2018-2029)
2.2 Global OTC Anti-Infective Medications Growth Trends by Region
2.2.1 OTC Anti-Infective Medications Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2018-2023)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2024-2029)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue OTC Anti-Infective Medications by Players
3.1.1 Global OTC Anti-Infective Medications Revenue by Players (2018-2023)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2018-2023)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Anti-Infective Medications, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2022
3.5 Global Key Players of OTC Anti-Infective Medications Head office and Area Served
3.6 Global Key Players of OTC Anti-Infective Medications, Product and Application
3.7 Global Key Players of OTC Anti-Infective Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC ANTI-INFECTIVE MEDICATIONS BREAKDOWN DATA BY TYPE
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2018-2023)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2024-2029)
5 OTC ANTI-INFECTIVE MEDICATIONS BREAKDOWN DATA BY APPLICATION
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2018-2023)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America OTC Anti-Infective Medications Market Size (2018-2029)
6.2 North America OTC Anti-Infective Medications Market Size by Type
6.2.1 North America OTC Anti-Infective Medications Market Size by Type (2018-2023)
6.2.2 North America OTC Anti-Infective Medications Market Size by Type (2024-2029)
6.2.3 North America OTC Anti-Infective Medications Market Share by Type (2018-2029)
6.3 North America OTC Anti-Infective Medications Market Size by Application
6.3.1 North America OTC Anti-Infective Medications Market Size by Application (2018-2023)
6.3.2 North America OTC Anti-Infective Medications Market Size by Application (2024-2029)
6.3.3 North America OTC Anti-Infective Medications Market Share by Application (2018-2029)
6.4 North America OTC Anti-Infective Medications Market Size by Country
6.4.1 North America OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America OTC Anti-Infective Medications Market Size by Country (2018-2023)
6.4.3 North America OTC Anti-Infective Medications Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe OTC Anti-Infective Medications Market Size (2018-2029)
7.2 Europe OTC Anti-Infective Medications Market Size by Type
7.2.1 Europe OTC Anti-Infective Medications Market Size by Type (2018-2023)
7.2.2 Europe OTC Anti-Infective Medications Market Size by Type (2024-2029)
7.2.3 Europe OTC Anti-Infective Medications Market Share by Type (2018-2029)
7.3 Europe OTC Anti-Infective Medications Market Size by Application
7.3.1 Europe OTC Anti-Infective Medications Market Size by Application (2018-2023)
7.3.2 Europe OTC Anti-Infective Medications Market Size by Application (2024-2029)
7.3.3 Europe OTC Anti-Infective Medications Market Share by Application (2018-2029)
7.4 Europe OTC Anti-Infective Medications Market Size by Country
7.4.1 Europe OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe OTC Anti-Infective Medications Market Size by Country (2018-2023)
7.4.3 Europe OTC Anti-Infective Medications Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China OTC Anti-Infective Medications Market Size (2018-2029)
8.2 China OTC Anti-Infective Medications Market Size by Type
8.2.1 China OTC Anti-Infective Medications Market Size by Type (2018-2023)
8.2.2 China OTC Anti-Infective Medications Market Size by Type (2024-2029)
8.2.3 China OTC Anti-Infective Medications Market Share by Type (2018-2029)
8.3 China OTC Anti-Infective Medications Market Size by Application
8.3.1 China OTC Anti-Infective Medications Market Size by Application (2018-2023)
8.3.2 China OTC Anti-Infective Medications Market Size by Application (2024-2029)
8.3.3 China OTC Anti-Infective Medications Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia OTC Anti-Infective Medications Market Size (2018-2029)
9.2 Asia OTC Anti-Infective Medications Market Size by Type
9.2.1 Asia OTC Anti-Infective Medications Market Size by Type (2018-2023)
9.2.2 Asia OTC Anti-Infective Medications Market Size by Type (2024-2029)
9.2.3 Asia OTC Anti-Infective Medications Market Share by Type (2018-2029)
9.3 Asia OTC Anti-Infective Medications Market Size by Application
9.3.1 Asia OTC Anti-Infective Medications Market Size by Application (2018-2023)
9.3.2 Asia OTC Anti-Infective Medications Market Size by Application (2024-2029)
9.3.3 Asia OTC Anti-Infective Medications Market Share by Application (2018-2029)
9.4 Asia OTC Anti-Infective Medications Market Size by Region
9.4.1 Asia OTC Anti-Infective Medications Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia OTC Anti-Infective Medications Market Size by Region (2018-2023)
9.4.3 Asia OTC Anti-Infective Medications Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.5.5 Abbott Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.8.5 Roche Recent Developments
11.9 NanoViricides
11.9.1 NanoViricides Company Details
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.9.5 NanoViricides Recent Developments
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Details
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.10.5 Novabay Pharmaceuticals Recent Developments
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Details
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.11.5 Optimer Pharmaceuticals Recent Developments
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Details
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.12.5 Basilea Pharmaceutica Recent Developments
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Details
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2018-2023)
11.13.5 MerLion Pharma Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungals
Table 3. Key Players of Antiseptic
Table 4. Key Players of Antiparasitics
Table 5. Global OTC Anti-Infective Medications Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global OTC Anti-Infective Medications Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Market Share by Region (2018-2023)
Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Market Share by Region (2024-2029)
Table 11. OTC Anti-Infective Medications Market Trends
Table 12. OTC Anti-Infective Medications Market Drivers
Table 13. OTC Anti-Infective Medications Market Challenges
Table 14. OTC Anti-Infective Medications Market Restraints
Table 15. Global OTC Anti-Infective Medications Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global OTC Anti-Infective Medications Revenue Share by Players (2018-2023)
Table 17. Global Top OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2022)
Table 18. Global OTC Anti-Infective Medications Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of OTC Anti-Infective Medications, Headquarters and Area Served
Table 21. Global Key Players of OTC Anti-Infective Medications, Product and Application
Table 22. Global Key Players of OTC Anti-Infective Medications, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2018-2023)
Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2024-2029)
Table 28. Global OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global OTC Anti-Infective Medications Revenue Share by Application (2018-2023)
Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global OTC Anti-Infective Medications Revenue Share by Application (2024-2029)
Table 32. North America OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 46. China OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 47. China OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 48. China OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 49. China OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia OTC Anti-Infective Medications Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia OTC Anti-Infective Medications Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia OTC Anti-Infective Medications Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline OTC Anti-Infective Medications Product
Table 67. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck OTC Anti-Infective Medications Product
Table 72. Merck Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 73. Merck Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer OTC Anti-Infective Medications Product
Table 77. Pfizer Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis OTC Anti-Infective Medications Product
Table 82. Novartis Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott OTC Anti-Infective Medications Product
Table 87. Abbott Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 88. Abbott Recent Developments
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi OTC Anti-Infective Medications Product
Table 92. Sanofi Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Developments
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb OTC Anti-Infective Medications Product
Table 97. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche OTC Anti-Infective Medications Product
Table 102. Roche Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 103. Roche Recent Developments
Table 104. NanoViricides Company Details
Table 105. NanoViricides Business Overview
Table 106. NanoViricides OTC Anti-Infective Medications Product
Table 107. NanoViricides Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 108. NanoViricides Recent Developments
Table 109. Novabay Pharmaceuticals Company Details
Table 110. Novabay Pharmaceuticals Business Overview
Table 111. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
Table 112. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 113. Novabay Pharmaceuticals Recent Developments
Table 114. Optimer Pharmaceuticals Company Details
Table 115. Optimer Pharmaceuticals Business Overview
Table 116. Optimer Pharmaceuticals OTC Anti-Infective Medications Product
Table 117. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 118. Optimer Pharmaceuticals Recent Developments
Table 119. Basilea Pharmaceutica Company Details
Table 120. Basilea Pharmaceutica Business Overview
Table 121. Basilea Pharmaceutica OTC Anti-Infective Medications Product
Table 122. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 123. Basilea Pharmaceutica Recent Developments
Table 124. MerLion Pharma Company Details
Table 125. MerLion Pharma Business Overview
Table 126. MerLion Pharma OTC Anti-Infective Medications Product
Table 127. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 128. MerLion Pharma Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungals
Table 3. Key Players of Antiseptic
Table 4. Key Players of Antiparasitics
Table 5. Global OTC Anti-Infective Medications Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global OTC Anti-Infective Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global OTC Anti-Infective Medications Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Market Share by Region (2018-2023)
Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Market Share by Region (2024-2029)
Table 11. OTC Anti-Infective Medications Market Trends
Table 12. OTC Anti-Infective Medications Market Drivers
Table 13. OTC Anti-Infective Medications Market Challenges
Table 14. OTC Anti-Infective Medications Market Restraints
Table 15. Global OTC Anti-Infective Medications Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global OTC Anti-Infective Medications Revenue Share by Players (2018-2023)
Table 17. Global Top OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2022)
Table 18. Global OTC Anti-Infective Medications Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of OTC Anti-Infective Medications, Headquarters and Area Served
Table 21. Global Key Players of OTC Anti-Infective Medications, Product and Application
Table 22. Global Key Players of OTC Anti-Infective Medications, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2018-2023)
Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2024-2029)
Table 28. Global OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global OTC Anti-Infective Medications Revenue Share by Application (2018-2023)
Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global OTC Anti-Infective Medications Revenue Share by Application (2024-2029)
Table 32. North America OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 46. China OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 47. China OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 48. China OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 49. China OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia OTC Anti-Infective Medications Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia OTC Anti-Infective Medications Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia OTC Anti-Infective Medications Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America OTC Anti-Infective Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size by Country (2024-2029) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline OTC Anti-Infective Medications Product
Table 67. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck OTC Anti-Infective Medications Product
Table 72. Merck Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 73. Merck Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer OTC Anti-Infective Medications Product
Table 77. Pfizer Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis OTC Anti-Infective Medications Product
Table 82. Novartis Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 83. Novartis Recent Developments
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott OTC Anti-Infective Medications Product
Table 87. Abbott Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 88. Abbott Recent Developments
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi OTC Anti-Infective Medications Product
Table 92. Sanofi Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Developments
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb OTC Anti-Infective Medications Product
Table 97. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche OTC Anti-Infective Medications Product
Table 102. Roche Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 103. Roche Recent Developments
Table 104. NanoViricides Company Details
Table 105. NanoViricides Business Overview
Table 106. NanoViricides OTC Anti-Infective Medications Product
Table 107. NanoViricides Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 108. NanoViricides Recent Developments
Table 109. Novabay Pharmaceuticals Company Details
Table 110. Novabay Pharmaceuticals Business Overview
Table 111. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
Table 112. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 113. Novabay Pharmaceuticals Recent Developments
Table 114. Optimer Pharmaceuticals Company Details
Table 115. Optimer Pharmaceuticals Business Overview
Table 116. Optimer Pharmaceuticals OTC Anti-Infective Medications Product
Table 117. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 118. Optimer Pharmaceuticals Recent Developments
Table 119. Basilea Pharmaceutica Company Details
Table 120. Basilea Pharmaceutica Business Overview
Table 121. Basilea Pharmaceutica OTC Anti-Infective Medications Product
Table 122. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 123. Basilea Pharmaceutica Recent Developments
Table 124. MerLion Pharma Company Details
Table 125. MerLion Pharma Business Overview
Table 126. MerLion Pharma OTC Anti-Infective Medications Product
Table 127. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2018-2023) & (US$ Million)
Table 128. MerLion Pharma Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global OTC Anti-Infective Medications Market Share by Type: 2022 VS 2029
Figure 3. Antifungals Features
Figure 4. Antiseptic Features
Figure 5. Antiparasitics Features
Figure 6. Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global OTC Anti-Infective Medications Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. OTC Anti-Infective Medications Report Years Considered
Figure 12. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global OTC Anti-Infective Medications Market Share by Region: 2022 VS 2029
Figure 15. Global OTC Anti-Infective Medications Market Share by Players in 2022
Figure 16. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2022
Figure 18. North America OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 20. North America OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 21. North America OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 22. United States OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 26. Europe OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 27. Europe OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 28. Germany OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 36. China OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 37. Asia OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 39. Asia OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 40. Asia OTC Anti-Infective Medications Market Share by Region (2018-2029)
Figure 41. Japan OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 51. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 60. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 61. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 64. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 65. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 66. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 67. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 68. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 69. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Figure 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global OTC Anti-Infective Medications Market Share by Type: 2022 VS 2029
Figure 3. Antifungals Features
Figure 4. Antiseptic Features
Figure 5. Antiparasitics Features
Figure 6. Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global OTC Anti-Infective Medications Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. OTC Anti-Infective Medications Report Years Considered
Figure 12. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global OTC Anti-Infective Medications Market Share by Region: 2022 VS 2029
Figure 15. Global OTC Anti-Infective Medications Market Share by Players in 2022
Figure 16. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2022
Figure 18. North America OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 20. North America OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 21. North America OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 22. United States OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 26. Europe OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 27. Europe OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 28. Germany OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 36. China OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 37. Asia OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 39. Asia OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 40. Asia OTC Anti-Infective Medications Market Share by Region (2018-2029)
Figure 41. Japan OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America OTC Anti-Infective Medications Market Share by Country (2018-2029)
Figure 51. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries OTC Anti-Infective Medications Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 60. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 61. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 64. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 65. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 66. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 67. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 68. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 69. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
